ArticleBMC nursing2026
Determinants of gout therapy non-adherence in patients attending an Egyptian rheumatology outpatient clinic.
Article in BMC nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-adherence to urate-lowering therapy (ULT) is a significant issue in the management of gout, a prevalent form of inflammatory arthritis that adversely affects patients' quality of life and burdens healthcare systems. Although ULT is effective in reducing serum uric acid levels, many patients fail to adhere to their medication regimens. Factors contributing to this non-adherence include treatment complexity, medication costs, side effects, forgetfulness, and individual health beliefs, as well as issues related to healthcare providers such as communication and education. Understanding these barriers is crucial for developing effective nursing interventions that enhance adherence and improve patient outcomes.
aimIdentify and analyze the factors influencing patient adherence to gout therapy and explore the barriers experienced by patients in a clinical setting.
methodsA descriptive research design was utilized with a convenience sample of 150 adults aged 21-60 years diagnosed with gout, who had been prescribed urate-lowering therapy for at least three months. Data collection occurred from November 1, 2024, to March 30, 2025. Participants were required to have the capacity to provide informed consent and understand the study requirements. Individuals with comorbidities affecting medication adherence, those currently enrolled in other clinical trials, and individuals unable to provide informed consent were excluded from the study. The study employed two questionnaires: a sociodemographic and clinical data questionnaire to gather relevant participant information and Intentional Non-Adherence Scale (INAS) to assess medication adherence.
resultsApproximately 60.7% of respondents indicate a low adherence level to medications, while 39.3% report a high adherence level to medications. Key factors affecting adherence include socio-demographic variables, such as higher rates among males and those aged 30-39, as well as sufficient income. In addition, the findings suggest that clinical data correlate with better adherence. CONCLUSION AND IMPLICATIONS: This study highlights critical socio-demographic and clinical characteristics of gout patients, emphasizing the need for enhanced public awareness campaigns, early screening programs, and targeted interventions to improve healthcare access and medication adherence among underserved populations. By addressing barriers such as medication costs and psychological factors through tailored nursing interventions and multidisciplinary collaboration, we can significantly enhance patient outcomes and quality of life for individuals living with gout.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.